J S Kennedy

Summary

Publications

  1. ncbi request reprint Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial
    J S Kennedy
    Indiana University School of Medicine, Department of Psychiatry, Indianapolis, Indiana, USA
    Int J Geriatr Psychiatry 18:1013-20. 2003
  2. ncbi request reprint The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's disease
    J S Kennedy
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
    Int J Geriatr Psychiatry 16:S24-32. 2001
  3. ncbi request reprint Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine
    F P Bymaster
    Neuroscience Research Division, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285 0501, USA
    Eur J Pharmacol 430:341-9. 2001
  4. ncbi request reprint Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease
    S P Roose
    Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    JAMA 279:287-91. 1998
  5. ncbi request reprint A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data
    J S Kennedy
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
    Int J Geriatr Psychiatry 16:S33-61. 2001

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial
    J S Kennedy
    Indiana University School of Medicine, Department of Psychiatry, Indianapolis, Indiana, USA
    Int J Geriatr Psychiatry 18:1013-20. 2003
    ..To compare the six-week clinical response and safety profile of schizophrenia patients, age > or =60 years, receiving olanzapine (OLZ) vs haloperidol (HAL) in a double blind, randomized trial...
  2. ncbi request reprint The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's disease
    J S Kennedy
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
    Int J Geriatr Psychiatry 16:S24-32. 2001
    ..In addition, changes in cognition were assessed in a subgroup of patients with mild to moderate cognitive impairment...
  3. ncbi request reprint Potent antagonism of 5-HT(3) and 5-HT(6) receptors by olanzapine
    F P Bymaster
    Neuroscience Research Division, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285 0501, USA
    Eur J Pharmacol 430:341-9. 2001
    ..Thus, olanzapine was not an agonist, but was a potent antagonist at 5-HT(6) receptors and had marked antagonism at 5-HT(3) receptors...
  4. ncbi request reprint Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease
    S P Roose
    Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    JAMA 279:287-91. 1998
    ..Patients with heart disease need a safe and effective treatment for depression...
  5. ncbi request reprint A current review of olanzapine's safety in the geriatric patient: from pre-clinical pharmacology to clinical data
    J S Kennedy
    Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA
    Int J Geriatr Psychiatry 16:S33-61. 2001
    ....